Patients TMS works. Why do fewer than 1% of eligible patients get it? A growing body of clinical evidence suggests that TMS can produce response rates of roughly 50-60% or higher.
News Cure HHT wins inaugural Prix Galien Patient First Award A patient-led initiative for hereditary haemorrhagic telangiectasia (HHT) has won the inaugural Prix Galien Patient First Award.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
